NGN Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
5
- Investments
-
59
- Portfolio
-
1
- Exits
-
34
NGN Capital General Information
Company Description
Founded in 2003, NGN Capital is a venture capital firm based in Stamford, Connecticut. The firm prefers to invest in companies operating in the healthcare, biotechnology, drug products, medical devices, and healthcare services sectors across the United States and Europe. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.ngncapital.comYear Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 60 Long Ridge Road
- Suite 402
- Stamford, CT 06902
- United States
NGN Capital Investments (59)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Cardiovalve | 01-Aug-2020 | Later Stage VC | Therapeutic Devices | Generating Revenue | ||
| OptiScan | 20-Mar-2019 | Monitoring Equipment | Bankruptcy: Admin/Reorg | |||
| Exosome Diagnostics | 05-Jul-2017 | Laboratory Services (Healthcare) | Generating Revenue | |||
| Exosome Diagnostics | 07-Jan-2016 | Laboratory Services (Healthcare) | Generating Revenue | |||
| Zenith Epigenetics | 23-Jul-2014 | Biotechnology | Generating Revenue | |||
| Exosome Diagnostics | 12-Mar-2014 | Laboratory Services (Healthcare) | Generating Revenue | |||
| Lean Startup Machine | 05-Mar-2014 | Business/Productivity Software | Out of Business | |||
| Endosense | 05-Mar-2013 | Surgical Devices | Generating Revenue | |||
| Cerapedics | 12-Dec-2012 | Later Stage VC | Surgical Devices | Generating Revenue | ||
| PIN Pharma | 01-Jan-2012 | Early Stage VC | Drug Discovery | Generating Revenue |
NGN Capital Exits (34)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Cardiovalve | 25-Jan-2022 | Merger/Acquisition | |
| Lean Startup Machine | 17-Dec-2021 | ||
| Cerapedics | 01-Aug-2021 | ||
| PIN Pharma | 01-Apr-2021 | ||
| OptiScan | 02-Jun-2020 | ||
| Zenith Epigenetics | 06-Mar-2020 | ||
| Exosome Diagnostics | 01-Aug-2018 | ||
| Valtech Cardio | 23-Jan-2017 | ||
| BeneChill | 01-Oct-2016 | Merger/Acquisition | |
| SpineView | 01-Oct-2016 | Out of Business |
NGN Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
NGN Capital Investments by Industry, Year, and Region
NGN Capital FAQs
-
What is NGN Capital?
Founded in 2003, NGN Capital is a venture capital firm based in Stamford, Connecticut.
-
When was NGN Capital founded?
NGN Capital was founded in 2003.
-
Where is NGN Capital headquartered?
NGN Capital is headquartered in Stamford, CT.
-
What is NGN Capital's total asset value?
NGN Capital has around in total assets under management.
-
How many investments has NGN Capital made?
NGN Capital has made 59 investments.
-
What has NGN Capital invested in?
NGN Capital has made numerous investments in companies like Cardiovalve, OptiScan, and Exosome Diagnostics within the Therapeutic Devices, Monitoring Equipment, and Laboratory Services (Healthcare) industries.
-
What has NGN Capital invested in recently?
NGN Capital's latest investment was on 01-Aug-2020 in Cardiovalve, a company within the Therapeutic Devices industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process